Dóra Richter, Dóra Erdélyi, Mercédesz Tőrincsi, László Hegedűs, Ágnes Gömöry, László Drahos, Gergő Gémes, József Kupai
{"title":"新型5′取代金鸡纳衍生的有机催化剂:合成、反应性和双活化电位","authors":"Dóra Richter, Dóra Erdélyi, Mercédesz Tőrincsi, László Hegedűs, Ágnes Gömöry, László Drahos, Gergő Gémes, József Kupai","doi":"10.1002/slct.202503793","DOIUrl":null,"url":null,"abstract":"<p>This work presents the synthesis of three little-investigated types of asymmetric cinchona organocatalysts. The cinchona moiety is considered one of the privileged chiral skeletons, and one of its well-known modifications involves attaching H-bond donor catalyst moieties at the C9 position. In our study, we aimed to introduce different types of H-bond donor functional groups, namely squaramide and thiourea, at the relatively unexplored 5’-position of the quinoline ring. Our goal was to compare the performance of these novel catalysts with those that are already established. Our test reaction was a pharmaceutically relevant Michael addition reaction, ultimately producing an intermediate for baclofen. The results indicated that the new substitution at the 5’-position did not yield significant advantages in terms of either yield (34%–97%) or enantiomeric excess (0%–18%). Additionally, we synthesised a unique type of asymmetric organocatalyst that incorporates both an H-bond donor and an enamine catalyst moiety, allowing for two different activation mechanisms. This innovative catalyst was also used in the synthesis of warfarin, resulting in lower yields (4%–26%) but promising enantiomeric excess values (13%–60%).</p>","PeriodicalId":146,"journal":{"name":"ChemistrySelect","volume":"10 26","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/slct.202503793","citationCount":"0","resultStr":"{\"title\":\"Novel 5’-Substituted Cinchona-Derived Organocatalysts: Synthesis, Reactivity, and Dual Activation Potential\",\"authors\":\"Dóra Richter, Dóra Erdélyi, Mercédesz Tőrincsi, László Hegedűs, Ágnes Gömöry, László Drahos, Gergő Gémes, József Kupai\",\"doi\":\"10.1002/slct.202503793\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>This work presents the synthesis of three little-investigated types of asymmetric cinchona organocatalysts. The cinchona moiety is considered one of the privileged chiral skeletons, and one of its well-known modifications involves attaching H-bond donor catalyst moieties at the C9 position. In our study, we aimed to introduce different types of H-bond donor functional groups, namely squaramide and thiourea, at the relatively unexplored 5’-position of the quinoline ring. Our goal was to compare the performance of these novel catalysts with those that are already established. Our test reaction was a pharmaceutically relevant Michael addition reaction, ultimately producing an intermediate for baclofen. The results indicated that the new substitution at the 5’-position did not yield significant advantages in terms of either yield (34%–97%) or enantiomeric excess (0%–18%). Additionally, we synthesised a unique type of asymmetric organocatalyst that incorporates both an H-bond donor and an enamine catalyst moiety, allowing for two different activation mechanisms. This innovative catalyst was also used in the synthesis of warfarin, resulting in lower yields (4%–26%) but promising enantiomeric excess values (13%–60%).</p>\",\"PeriodicalId\":146,\"journal\":{\"name\":\"ChemistrySelect\",\"volume\":\"10 26\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-07-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/slct.202503793\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ChemistrySelect\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/slct.202503793\",\"RegionNum\":4,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemistrySelect","FirstCategoryId":"92","ListUrlMain":"https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/slct.202503793","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Novel 5’-Substituted Cinchona-Derived Organocatalysts: Synthesis, Reactivity, and Dual Activation Potential
This work presents the synthesis of three little-investigated types of asymmetric cinchona organocatalysts. The cinchona moiety is considered one of the privileged chiral skeletons, and one of its well-known modifications involves attaching H-bond donor catalyst moieties at the C9 position. In our study, we aimed to introduce different types of H-bond donor functional groups, namely squaramide and thiourea, at the relatively unexplored 5’-position of the quinoline ring. Our goal was to compare the performance of these novel catalysts with those that are already established. Our test reaction was a pharmaceutically relevant Michael addition reaction, ultimately producing an intermediate for baclofen. The results indicated that the new substitution at the 5’-position did not yield significant advantages in terms of either yield (34%–97%) or enantiomeric excess (0%–18%). Additionally, we synthesised a unique type of asymmetric organocatalyst that incorporates both an H-bond donor and an enamine catalyst moiety, allowing for two different activation mechanisms. This innovative catalyst was also used in the synthesis of warfarin, resulting in lower yields (4%–26%) but promising enantiomeric excess values (13%–60%).
期刊介绍:
ChemistrySelect is the latest journal from ChemPubSoc Europe and Wiley-VCH. It offers researchers a quality society-owned journal in which to publish their work in all areas of chemistry. Manuscripts are evaluated by active researchers to ensure they add meaningfully to the scientific literature, and those accepted are processed quickly to ensure rapid online publication.